首页 | 本学科首页   官方微博 | 高级检索  
     


The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening
Authors:Arthur I. Kooyker  Esther Toes-Zoutendijk  Annemieke W.J. Opstal-van Winden  Manon C.W. Spaander  Maaike Buskermolen  Hanneke J. van Vuuren  Ernst J. Kuipers  Folkert J. van Kemenade  Chris Ramakers  Maarten G.J. Thomeer  Evelien Dekker  Iris D. Nagtegaal  Harry J. de Koning  Monique E. van Leerdam  Iris Lansdorp-Vogelaar
Affiliation:1. Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands;2. Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands;3. Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands;4. Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands;5. Department of Radiology, Erasmus University Medical Center, Rotterdam, The Netherlands;6. Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers – Academic Medical Center, Amsterdam, The Netherlands;7. Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands;8. Department of Gastroenterology, Netherlands Cancer Institute – Antoni van Leeuwenhoek, Amsterdam, The Netherlands
Abstract:
The Dutch colorectal cancer (CRC) screening program started in 2014, inviting the target population biennially to perform a fecal immunochemical test (FIT). We obtained prospectively collected data from the national screening information-system to present the results of the second round (2016) and evaluate the impact of increasing the FIT cut-off halfway through the first round from 15 to 47 μg Hb/g feces on outcomes in the second round. Second round screening was done with a 47 μg Hb/g feces FIT cut-off. Participants were classified based on first round participation status as either FIT (15,47) or FIT (47,47) participants, and previous nonparticipants. In total, 348,891 (75.9%) out of 459,740 invitees participated in the second round. Participation rates were 93.4% among previous participants and 21.0% among previous non-participants. FIT(47,47) participants had a significantly higher detection rate of AN (15.3 vs. 10.4 per 1,000 participants) compared to FIT(15,47) participants in the second round, while their cumulative detection rate of AN over two rounds was significantly lower (45.6 vs. 52.6 per 1,000 participants). Our results showed that participation in the Dutch CRC screening program was consistently high and that second round detection rates depended on the first round FIT cut-off. The cumulative detection over two rounds was higher among FIT(15,47) participants. These findings suggest that a substantial part of, but not all the missed findings in the first round due to the increased FIT cut-off were detected in the subsequent round.
Keywords:colorectal cancer  colorectal cancer screening  fecal immunochemical test  colorectal neoplasia  colonoscopy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号